Lyndra Therapeutics is a biotechnology company focused on developing novel oral drug delivery platforms to improve medication adherence and patient outcomes. Their technology allows for the controlled release of drug compounds over an extended period of time, reducing the need for frequent dosing and increasing patient convenience. With a diverse pipeline of innovative therapies, Lyndra is committed to revolutionizing the way medications are delivered and improving patient care.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

9 Patents

#41 in Watertown, MA

#1,926 in Massachusetts

#32,605 in US

Watertown, MA, United States of America

Lyndra Therapeutics, Inc.

Forward Citations = 19

30 inventors:

Tyler Grant (6 out of 21 patents)

Rosemary Lynn Kanasty (6 out of 10 patents)

Andrew Bellinger (5 out of 21 patents)

4. Nupura Bhise (4 out of 4 patents)

5. Colin R Gardner (3 out of 13 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Lyndra Therapeutics, Inc.. Retrieved from https://idiyas.com/company/lyndra-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

8 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]